Test-retest reliability of neural alcohol cue-reactivity: Is there light at the end of the magnetic resonance imaging tube?
- PMID: 34132011
- DOI: 10.1111/adb.13069
Test-retest reliability of neural alcohol cue-reactivity: Is there light at the end of the magnetic resonance imaging tube?
Abstract
Over the last decades, the assessment of alcohol cue-reactivity gained popularity in addiction research, and efforts were undertaken to establish neural biomarkers. This attempt however depends on the reliability of cue-induced brain activation. Thus, we assessed test-retest reliability of alcohol cue-reactivity and its implications for imaging studies in addiction. We investigated test-retest reliability of alcohol cue-induced brain activation in 144 alcohol-dependent patients over 2 weeks. We computed established reliability estimates, such as intraclass correlation (ICC), Dice and Jaccard coefficients, for the three contrast conditions of interest: 'alcohol', 'neutral' and the 'alcohol versus neutral' difference contrast. We also investigated how test-retest reliability of the different contrasts affected the capacity to establishing associations with clinical data and determining effect size estimates. Whereas brain activation, indexed by the constituting contrast conditions 'alcohol' and 'neutral' separately, displayed overall moderate (ICC > 0.4) to good (ICC > 0.75) test-retest reliability in areas of the mesocorticolimbic system, the difference contrast 'alcohol versus neutral' showed poor overall reliability (ICC < 0.40), which was related to the intercorrelation between the constituting conditions. Data simulations and analyses of craving data confirmed that the low reliability of the difference contrast substantially limited the capacity to establish associations with clinical data and precisely estimate effect sizes. Future research on alcohol cue-reactivity should be cautioned by the low reliability of the common 'alcohol versus neutral' difference contrast. We propose that this limitation can be overcome by using the constituent task conditions as an individual difference measure, when intending to longitudinally monitor brain responses.
Keywords: Dice; Jaccard; alcohol cue-reactivity; fMRI; intraclass correlation; reliability.
© 2021 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Similar articles
-
Reliability of neural food cue-reactivity in participants with obesity undergoing bariatric surgery: a 26-week longitudinal fMRI study.Eur Arch Psychiatry Clin Neurosci. 2021 Aug;271(5):951-962. doi: 10.1007/s00406-020-01218-8. Epub 2020 Dec 17. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 33331960 Free PMC article.
-
Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river?Psychoneuroendocrinology. 2019 Feb;100:1-9. doi: 10.1016/j.psyneuen.2018.09.026. Epub 2018 Sep 18. Psychoneuroendocrinology. 2019. PMID: 30268001
-
Neural responses to stress and alcohol cues in individuals with pain with and without alcohol use disorder.Addict Biol. 2024 Dec;29(12):e70010. doi: 10.1111/adb.70010. Addict Biol. 2024. PMID: 39660770 Free PMC article.
-
Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies.Neurosci Biobehav Rev. 2021 Sep;128:294-310. doi: 10.1016/j.neubiorev.2021.06.031. Epub 2021 Jun 23. Neurosci Biobehav Rev. 2021. PMID: 34171325 Review.
-
Test-retest reliability of longitudinal task-based fMRI: Implications for developmental studies.Dev Cogn Neurosci. 2018 Oct;33:17-26. doi: 10.1016/j.dcn.2017.07.001. Epub 2017 Jul 13. Dev Cogn Neurosci. 2018. PMID: 29158072 Free PMC article. Review.
Cited by
-
Neural cue reactivity is not stronger in male than in female patients with alcohol use disorder.Front Behav Neurosci. 2022 Nov 16;16:1039917. doi: 10.3389/fnbeh.2022.1039917. eCollection 2022. Front Behav Neurosci. 2022. PMID: 36467741 Free PMC article.
-
Neuroimaging Biomarkers in Addiction.medRxiv [Preprint]. 2024 Sep 3:2024.09.02.24312084. doi: 10.1101/2024.09.02.24312084. medRxiv. 2024. PMID: 39281741 Free PMC article. Preprint.
-
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.Alcohol Clin Exp Res (Hoboken). 2023 Sep;47(9):1629-1645. doi: 10.1111/acer.15143. Epub 2023 Jul 23. Alcohol Clin Exp Res (Hoboken). 2023. PMID: 37423771 Free PMC article. Review.
-
The effects of N-acetyl cysteine on intrinsic functional connectivity and neural alcohol cue reactivity in treatment-seeking individuals with alcohol use disorder: a preliminary study.Psychopharmacology (Berl). 2025 Jan;242(1):149-160. doi: 10.1007/s00213-024-06656-z. Epub 2024 Aug 5. Psychopharmacology (Berl). 2025. PMID: 39102049 Free PMC article. Clinical Trial.
-
The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial.Contemp Clin Trials Commun. 2024 Aug 13;41:101341. doi: 10.1016/j.conctc.2024.101341. eCollection 2024 Oct. Contemp Clin Trials Commun. 2024. PMID: 39252861 Free PMC article.
References
REFERENCES
-
- Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am Psychiatric Assoc. 2010;167(7):748-751.
-
- Voon V, Grodin E, Mandali A, et al. Addictions NeuroImaging Assessment (ANIA): towards an integrative framework for alcohol use disorder. Neurosci Biobehav Rev. 2020;113:492-506.
-
- Bach P, Weil G, Pompili E, et al. Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol. 2020;25(1):e12717. https://doi.org/10.1111/adb.12717
-
- Mann K, Vollstädt-Klein S, Reinhard I, et al. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging. Alcohol Clin Exp Res. 2014;38(11):2754-2762.
-
- Schacht JP, Randall PK, Latham PK, et al. Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status. Neuropsychopharmacology. 2017;42(13):2640-2653.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical